Answers are grounded in this paper and cite their sources.
Network SDS Indicators and a Monitoring Framework Launching a data revolution for the Sustainable Development Goals. Available from: https://indicators.report/targets/3-4/ . Hecker J, Freijer K, Hiligsmann M, Evers SMAA. Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life. BMC Public Health. 2022;22:46. Article CAS Google Scholar Nielsen HJ, Nedrebø BG, Fosså A, Andersen JR, Assmus J, Dagsland VH, et al. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obesity. 2022;46:739–49. Article CAS Google Scholar Thomas CE, Mauer EA, Shukla AP, Rathi S, Aronne LJ. Low adoption of weight loss medications: A comparison of prescribing patterns of anti-obesity pharmacotherapies and SGLT2s. Obesity. 2016;24:1955–61. Article Google Scholar Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, et al. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity (Silver Spring). 2020;28(6):1050–61. Agency EM Wegovy 2022. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy . Gomez G, Stanford FCUS. health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity. Int J Obes. 2018;42:495–500. Article CAS Google Scholar Justice TFMo. Social Code Book V - Statutory Health Insurance - (Article 1 of the Act of December 20, 1988, BGBl. I S. 2477) § 34 Excluded drugs, remedies and aids. Available from: https://www.gesetze-im.internet.de/sgb_5/__34.html . Wenar L John RawlsSummer 2021. Morgan SG, Lee A. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries. BMJ Open. 2017;7:e014287. Article Google Scholar Rosenbaum M, Leibel RL. Adaptive thermogenesis in humans. Int J Obes. 2010;34 Suppl 1 (0 1)):S47–55. Kolata G The Doctor Prescribed an Obesity Drug. Her Insurer Called It ‘Vanity.’ The New York Times 2022. Available from: https://www.nytimes.com/2022/05/31/health/obesity-drugs.insurance.html?referringSource=articleShare . All countries significantly off track to meet 2025 WHO targets on Obesity [press release]. World Obesity Federation 2020. Download references
No takes yet. Share an insight, caveat, or question.
Roser et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: